Arkolith/Insider Trading/NBP/Form 4

Fu Wei

DirectorNovaBridge Biosciences (NBP) · full profile →Form 4 · filed Jun 30, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Grant(A)725K—$0725K
Jun 29, 2026Grant(A)1.1M—$01.1M
Jun 29, 2026Grant(A)1.1M—$01.1M
Jun 29, 2026Grant(A)1.0M—$01.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001885756-26-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML